You can learn more about our research and development through scientific publications and presentations from the Aeglea team and our collaborators.

Select a Program

March 2018

Once-Weekly Intravenous Administration of Pegzilarginase Produces Marked and Sustained Reductions in Plasma Arginine Levels in Adults with Arginase 1 Deficiency: Early Results from a Phase 1/2 Open-Label Study of Pegzilarginase

Get In Touch With Us